{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:09:48Z","timestamp":1791828588838,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Nutr"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background\/Objectives<\/jats:title>\n            <jats:p>Glycogen storage diseases type VI (GSD-VI) and type IX (GSD-IX) are rare inherited metabolic disorders caused by enzyme deficiencies that disrupt glycogen metabolism. The aim of this study was to analyze the clinical features, nutritional management and geno-phenotyping of clinical nutrition in a cohort of patients with GSD-VI and GSD-IX.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Subjects\/Methods<\/jats:title>\n            <jats:p>A retrospective cohort study was conducted with 16 patients with GSD-VI and GSD-IX. Demographic characteristics, clinical and laboratory findings, and nutritional treatment outcomes were collected and analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The mean patient age was 10.57 years (\u00b14.81). The distribution of the diagnoses was as follows: GSD-IXa (3), GSD-IXb (6), GSD-IXc (1), and GSD-VI (6). The average age at diagnosis was 36.5 months (\u00b142.2) (13\u2013114 months) in the GSD-VI group. Among the GSD-IX subgroups, the mean age at diagnosis varied: 23.3months (\u00b14.16) for GSD-IXa, 35.7months (\u00b117.5) for GSD-IXb, and 78months for GSD-IXc. Over the course of the study (4.5\u2009\u00b1\u20091.77 years), protein intake in GSD VI patients increased by 1.05\u2009g\/kg\/day (91.3% increase), while in GSD IX patients, it rose by 1.09\u2009g\/kg\/day (94% rise). Uncooked cornstarch (UCS) started at 1\u2009g\/kg\/day for GSD-VI and 0.85\u2009g\/kg\/day for GSD-IX, later reduced to 0.71\u2009g\/kg\/day (29% decrease) and 0.52\u2009g\/kg\/day (60% reduction), respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Overall, this paper provides valuable insights into managing GSDVI and GSDIX patients, emphasizing the role of a high-protein diet aligned with the disease\u2019s pathophysiology and the potential of genotyping to enhance nutritional treatment protocols.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1038\/s41430-025-01614-0","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:37:59Z","timestamp":1744259879000},"page":"723-730","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nutritional management and geno-phenotyping of clinical nutrition in patients with glycogen storage diseases type VI and IX"],"prefix":"10.1038","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9574-7841","authenticated-orcid":false,"given":"Sema","family":"Kalkan U\u00e7ar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alperen","family":"Elek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Havva","family":"Yaz\u0131c\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5851-1012","authenticated-orcid":false,"given":"Yasemin","family":"Atik Alt\u0131nok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe","family":"Y\u00fcksel Yanbolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fehime","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0015-9807","authenticated-orcid":false,"given":"Merve","family":"Yolda\u015f \u00c7elik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u00e7a","family":"Aykut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4109-9401","authenticated-orcid":false,"given":"Asude","family":"Durmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Canda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"\u00c7oker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"1614_CR1","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00431-019-03499-1","volume":"179","author":"TR Aeppli","year":"2020","unstructured":"Aeppli TR, Rymen D, Allegri G, Bode PK, Haberle J. Glycogen storage disease type VI: clinical course and molecular background. Eur J Pediatr. 2020;179:405\u201313.","journal-title":"Eur J Pediatr"},{"key":"1614_CR2","first-page":"35","volume":"9","author":"HG Hers","year":"1959","unstructured":"Hers HG. Enzymatic studies of hepatic fragments; application to the classification of glycogenoses. Rev Int Hepatol. 1959;9:35\u201355.","journal-title":"Rev Int Hepatol"},{"key":"1614_CR3","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41436-018-0364-2","volume":"21","author":"PS Kishnani","year":"2019","unstructured":"Kishnani PS, Goldstein J, Austin SL, Arn P, Bachrach B, Bali DS, et al. Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2019;21:772\u201389.","journal-title":"Genet Med"},{"key":"1614_CR4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1086\/301790","volume":"62","author":"B Burwinkel","year":"1998","unstructured":"Burwinkel B, Bakker HD, Herschkovitz E, Moses SW, Shin YS, Kilimann MW. Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI. Am J Hum Genet. 1998;62:785\u201391.","journal-title":"Am J Hum Genet"},{"key":"1614_CR5","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s10545-007-0499-9","volume":"30","author":"NJ Beauchamp","year":"2007","unstructured":"Beauchamp NJ, Taybert J, Champion MP, Layet V, Heinz-Erian P, Dalton A, et al. High frequency of missense mutations in glycogen storage disease type VI. J Inherit Metab Dis. 2007;30:722\u201334.","journal-title":"J Inherit Metab Dis"},{"key":"1614_CR6","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1515\/jpem-2020-0173","volume":"33","author":"SQ Lu","year":"2020","unstructured":"Lu SQ, Feng JY, Liu J, Xie XB, Lu Y, Abuduxikuer K. Glycogen storage disease type VI can progress to cirrhosis: ten Chinese patients with GSD VI and a literature review. J Pediatr Endocrinol Metab. 2020;33:1321\u201333.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"1614_CR7","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.transproceed.2011.01.129","volume":"43","author":"TM Manzia","year":"2011","unstructured":"Manzia TM, Angelico R, Toti L, Cillis A, Ciano P, Orlando G, et al. Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: two case reports. Transplant Proc. 2011;43:1181\u20133.","journal-title":"Transplant Proc"},{"key":"1614_CR8","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1111\/j.1442-200X.2010.03073.x","volume":"52","author":"A Ogawa","year":"2010","unstructured":"Ogawa A, Ogawa E, Yamamoto S, Fukuda T, Sugie H, Kohno Y. Case of glycogen storage disease type VI (phosphorylase deficiency) complicated by focal nodular hyperplasia. Pediatr Int. 2010;52:e150\u20133.","journal-title":"Pediatr Int"},{"key":"1614_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ymgme.2014.09.005","volume":"113","author":"A Roscher","year":"2014","unstructured":"Roscher A, Patel J, Hewson S, Nagy L, Feigenbaum A, Kronick J, et al. The natural history of glycogen storage disease types VI and IX: Long-term outcome from the largest metabolic center in Canada. Mol Genet Metab. 2014;113:171\u20136.","journal-title":"Mol Genet Metab"},{"key":"1614_CR10","unstructured":"Turkish Statistical Institute (T\u00dc\u0130K). \u0130statistiklerle Aile. 2022. Retrieved from https:\/\/data.tuik.gov.tr\/. [Available from: https:\/\/data.tuik.gov.tr\/Bulten\/Index?p=Istatistiklerle-Aile-2021-45632."},{"key":"1614_CR11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/hmg\/7.5.865","volume":"7","author":"S Chang","year":"1998","unstructured":"Chang S, Rosenberg MJ, Morton H, Francomano CA, Biesecker LG. Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI. Hum Mol Genet. 1998;7:865\u201370.","journal-title":"Hum Mol Genet"},{"key":"1614_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02431-5","volume":"17","author":"F Tagliaferri","year":"2022","unstructured":"Tagliaferri F, Massese M, Russo L, Commone A, Gasperini S, Pretese R, et al. Hepatic glycogen storage diseases type 0, VI and IX: description of an italian cohort. Orphanet J Rare Dis. 2022;17:285.","journal-title":"Orphanet J Rare Dis"},{"key":"1614_CR13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ymgme.2007.06.007","volume":"92","author":"NJ Beauchamp","year":"2007","unstructured":"Beauchamp NJ, Dalton A, Ramaswami U, Niinikoski H, Mention K, Kenny P, et al. Glycogen storage disease type IX: High variability in clinical phenotype. Mol Genet Metab. 2007;92:88\u201399.","journal-title":"Mol Genet Metab"},{"key":"1614_CR14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s004390050715","volume":"102","author":"B Burwinkel","year":"1998","unstructured":"Burwinkel B, Amat L, Gray RG, Matsuo N, Muroya K, Narisawa K, et al. Variability of biochemical and clinical phenotype in X-linked liver glycogenosis with mutations in the phosphorylase kinase PHKA2 gene. Hum Genet. 1998;102:423\u20139.","journal-title":"Hum Genet"},{"key":"1614_CR15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/hmg\/5.5.653","volume":"5","author":"B Burwinkel","year":"1996","unstructured":"Burwinkel B, Shin YS, Bakker HD, Deutsch J, Lozano MJ, Maire I, et al. Mutation hotspots in the PHKA2 gene in X-linked liver glycogenosis due to phosphorylase kinase deficiency with atypical activity in blood cells (XLG2). Hum Mol Genet. 1996;5:653\u20138.","journal-title":"Hum Mol Genet"},{"key":"1614_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ymgme.2011.05.010","volume":"104","author":"A Davit-Spraul","year":"2011","unstructured":"Davit-Spraul A, Piraud M, Dobbelaere D, Valayannopoulos V, Labrune P, Habes D, et al. Liver glycogen storage diseases due to phosphorylase system deficiencies: diagnosis thanks to non invasive blood enzymatic and molecular studies. Mol Genet Metab. 2011;104:137\u201343.","journal-title":"Mol Genet Metab"},{"key":"1614_CR17","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s004310050967","volume":"157","author":"J Hendrickx","year":"1998","unstructured":"Hendrickx J, Bosshard NU, Willems P, Gitzelmann R. Clinical, biochemical and molecular findings in a patient with X-linked liver glycogenosis followed for 40 years. Eur J Pediatr. 1998;157:919\u201323.","journal-title":"Eur J Pediatr"},{"key":"1614_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/MPG.0b013e31823276ea","volume":"55","author":"AO Johnson","year":"2012","unstructured":"Johnson AO, Goldstein JL, Bali D. Glycogen storage disease type IX: novel PHKA2 missense mutation and cirrhosis. J Pediatr Gastroenterol Nutr. 2012;55:90\u20132.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1614_CR19","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ymgme.2010.11.004","volume":"102","author":"CK Lau","year":"2011","unstructured":"Lau CK, Hui J, Fong FN, To KF, Fok TF, Tang NL, et al. Novel mutations in PHKA2 gene in glycogen storage disease type IX patients from Hong Kong, China. Mol Genet Metab. 2011;102:222\u20135.","journal-title":"Mol Genet Metab"},{"key":"1614_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ymgme.2013.03.009","volume":"109","author":"LA Tsilianidis","year":"2013","unstructured":"Tsilianidis LA, Fiske LM, Siegel S, Lumpkin C, Hoyt K, Wasserstein M, et al. Aggressive therapy improves cirrhosis in glycogen storage disease type IX. Mol Genet Metab. 2013;109:179\u201382.","journal-title":"Mol Genet Metab"},{"key":"1614_CR21","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ymgme.2011.08.021","volume":"104","author":"S Achouitar","year":"2011","unstructured":"Achouitar S, Goldstein JL, Mohamed M, Austin S, Boyette K, Blanpain FM, et al. Common mutation in the PHKA2 gene with variable phenotype in patients with liver phosphorylase b kinase deficiency. Mol Genet Metab. 2011;104:691\u20134.","journal-title":"Mol Genet Metab"},{"key":"1614_CR22","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1093\/hmg\/6.7.1109","volume":"6","author":"B Burwinkel","year":"1997","unstructured":"Burwinkel B, Maichele AJ, Aagenaes O, Bakker HD, Lerner A, Shin YS, et al. Autosomal glycogenosis of liver and muscle due to phosphorylase kinase deficiency is caused by mutations in the phosphorylase kinase beta subunit (PHKB). Hum Mol Genet. 1997;6:1109\u201315.","journal-title":"Hum Mol Genet"},{"key":"1614_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s004390050608","volume":"101","author":"B Burwinkel","year":"1997","unstructured":"Burwinkel B, Moses SW, Kilimann MW. Phosphorylase-kinase-deficient liver glycogenosis with an unusual biochemical phenotype in blood cells associated with a missense mutation in the beta subunit gene (PHKB). Hum Genet. 1997;101:170\u20134.","journal-title":"Hum Genet"},{"key":"1614_CR24","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00431-013-2223-0","volume":"173","author":"B Albash","year":"2014","unstructured":"Albash B, Imtiaz F, Al-Zaidan H, Al-Manea H, Banemai M, Allam R, et al. Novel PHKG2 mutation causing GSD IX with prominent liver disease: report of three cases and review of literature. Eur J Pediatr. 2014;173:647\u201353.","journal-title":"Eur J Pediatr"},{"key":"1614_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ymgme.2013.12.008","volume":"111","author":"DS Bali","year":"2014","unstructured":"Bali DS, Goldstein JL, Fredrickson K, Rehder C, Boney A, Austin S, et al. Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene. Mol Genet Metab. 2014;111:309\u201313.","journal-title":"Mol Genet Metab"},{"key":"1614_CR26","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1203\/01.PDR.0000088069.09275.10","volume":"54","author":"B Burwinkel","year":"2003","unstructured":"Burwinkel B, Rootwelt T, Kvittingen EA, Chakraborty PK, Kilimann MW. Severe phenotype of phosphorylase kinase-deficient liver glycogenosis with mutations in the PHKG2 gene. Pediatr Res. 2003;54:834\u20139.","journal-title":"Pediatr Res"},{"key":"1614_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1177\/1942602X09342443","volume":"24","author":"JK Kadohiro","year":"2009","unstructured":"Kadohiro JK. Managing hypoglycemia in the school setting. NASN Sch Nurse. 2009;24:190\u20133.","journal-title":"NASN Sch Nurse"},{"key":"1614_CR28","first-page":"41","volume":"28","author":"IJ Hoogeveen","year":"2016","unstructured":"Hoogeveen IJ, van der Ende RM, van Spronsen FJ, de Boer F, Heiner-Fokkema MR, Derks TG. Normoglycemic Ketonemia as Biochemical Presentation in Ketotic Glycogen Storage Disease. JIMD Rep. 2016;28:41\u20137.","journal-title":"JIMD Rep"},{"key":"1614_CR29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jhep.2013.03.016","volume":"59","author":"R Lichtinghagen","year":"2013","unstructured":"Lichtinghagen R, Pietsch D, Bantel H, Manns MP, Brand K, Bahr MJ. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values. J Hepatol. 2013;59:236\u201342.","journal-title":"J Hepatol"},{"key":"1614_CR30","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s12664-017-0784-y","volume":"36","author":"S Alam","year":"2017","unstructured":"Alam S, Islam MS, Islam S, Mustafa G, Saleh AA, Ahmad N. Association of single nucleotide polymorphism at PNPLA3 with fatty liver, steatohepatitis, and cirrhosis of liver. Indian J Gastroenterol. 2017;36:366\u201372.","journal-title":"Indian J Gastroenterol"},{"key":"1614_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ymgme.2020.10.004","volume":"131","author":"SA Fernandes","year":"2020","unstructured":"Fernandes SA, Cooper GE, Gibson RA, Kishnani PS. Benign or not benign? Deep phenotyping of liver Glycogen Storage Disease IX. Mol Genet Metab. 2020;131:299\u2013305.","journal-title":"Mol Genet Metab"},{"key":"1614_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12887-021-02648-6","volume":"21","author":"Z Beyzaei","year":"2021","unstructured":"Beyzaei Z, Ezgu F, Geramizadeh B, Alborzi A, Shojazadeh A. Novel mutations in the PHKB gene in an iranian girl with severe liver involvement and glycogen storage disease type IX: a case report and review of literature. BMC Pediatr. 2021;21:175.","journal-title":"BMC Pediatr"},{"key":"1614_CR33","doi-asserted-by":"publisher","first-page":"e25520","DOI":"10.1097\/MD.0000000000025520","volume":"100","author":"Q Zhan","year":"2021","unstructured":"Zhan Q, Lv Z, Tang Q, Huang L, Chen X, Yang M, et al. Glycogen storage disease type VI with a novel PYGL mutation: Two case reports and literature review. Medicine. 2021;100:e25520.","journal-title":"Medicine"},{"key":"1614_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2023.107525","volume":"138","author":"RL Koch","year":"2023","unstructured":"Koch RL, Soler-Alfonso C, Kiely BT, Asai A, Smith AL, Bali DS, et al. Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource. Mol Genet Metab. 2023;138:107525.","journal-title":"Mol Genet Metab"}],"container-title":["European Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41430-025-01614-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41430-025-01614-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41430-025-01614-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T10:51:12Z","timestamp":1757155872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41430-025-01614-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1614"],"URL":"https:\/\/doi.org\/10.1038\/s41430-025-01614-0","relation":{},"ISSN":["0954-3007","1476-5640"],"issn-type":[{"value":"0954-3007","type":"print"},{"value":"1476-5640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"12 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was obtained from all participating patients and\/or parents as appropriate for the age of the child.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Ege University Faculty of Medicine (approval number: 23-8T\/75).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}